Further research is needed to investigate whether the co-expression of PTHrP and ezrin has a synergistic or additive effect on tumor behavior and metastasis and to elucidate the underlying mechanisms of their interaction and their combined impact on breast cancer progression. Here, EZR is linked to neoplasm.